Iovance Biotherapeutics Files Prospectus For Offering Mixed Shelf; Terms Undisclosed

Benzinga Newsdesk www.benzinga.com Neutral 93.2%

Neg 0% Neu 93.2% Pos 0%

https://www.sec.gov/Archives/edgar/data/1425205/000110465926075778/iova-20260618xs3asr.htm

Comments

No comments yet. Be the first!